News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mercator Therapeutics and X-BODY Biosciences Establish Alliance to Generate Antibody Cancer Therapeutics


1/6/2011 8:47:22 AM

(BUSINESS WIRE)--Mercator Therapeutics, Inc., the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs, and X-BODY BioSciences, Inc., a developer of monoclonal antibody therapeutics, today announced a multi-target research collaboration. The companies will collaborate to develop antibodies to four of Mercator’s cancer targets identified using Mercator’s proprietary in vivo screening technology.

Read at Business Wire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES